Sanofi’s Dupixent funded in Wales and Scotland for adolescents with eczema

Sanofi’s Dupixent funded in Wales and Scotland for adolescents with eczema

Source: 
Pharmaforum
snippet: 

Sanofi’s Dupixent (dupilumab) has been cleared for NHS funding in Wales and Scotland in adolescents with severe eczema, also known as atopic dermatitis.